Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. - Wikidata - wikimedia - TriplyDB

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.

http://www.wikidata.org/entity/Q46932585

about

HPV & head and neck cancer: a descriptive update De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy with or without adjuvant chemotherapy for locally advanced nasopharyngeal carcinoma Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy Neoadjuvant chemotherapy in oral cancers: Selecting the right patients Human Papillomavirus (HPV)-associated Oral Cancers and Treatment Strategies The current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neck The role of systemic treatment before, during, and after definitive treatment Time course and predictors for cancer-related fatigue in a series of oropharyngeal cancer patients treated with chemoradiation therapy Role of chemotherapy in nasopharyngeal carcinoma What is the best treatment for patients with human papillomavirus-positive and -negative oropharyngeal cancer?Prognostic value of HIFs expression in head and neck cancer: a systematic review Emerging Phytochemicals for the Prevention and Treatment of Head and Neck Cancer An update on larynx cancer Optimal management of the elderly patient with head and neck cancer: Issues regarding surgery, irradiation and chemotherapy Genome stability pathways in head and neck cancers Collagen gel droplet-embedded culture drug sensitivity testing in squamous cell carcinoma cell lines derived from human oral cancers: Optimal contact concentrations of cisplatin and fluorouracil Evidence for mesenchymal-like sub-populations within squamous cell carcinomas possessing chemoresistance and phenotypic plasticity.Evidence-based review of treatment options for patients with glottic cancer.Grape seed proanthocyanidins inhibit the invasiveness of human HNSCC cells by targeting EGFR and reversing the epithelial-to-mesenchymal transition A comparison of overall survival for patients with T4 larynx cancer treated with surgical versus organ-preservation approaches: A National Cancer Data Base analysis.Sequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancer.Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation.S-1 plus cisplatin: another option in the treatment of advanced head and neck cancer?Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. E Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for esophageal cancer.A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer.Safety and efficacy of concurrent carboplatin plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.Modified docetaxel, cisplatin and fluorouracil therapy as the first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective study.Gemcitabine/cisplatin induction chemotherapy before concurrent chemotherapy and intensity-modulated radiotherapy improves outcomes for locoregionally advanced nasopharyngeal carcinoma.A non-randomized comparison of gemcitabine-based chemoradiation with or without induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck.Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial.Phase I adjuvant radiation with docetaxel in high-risk head and neck cancer.Palliative treatment of patients with inoperable locally advanced, recurrent or metastatic head and neck squamous cell cancer, using a low-dose and personalized chemotherapeutic regimen.Concurrent chemoradiotherapy followed by adjuvant chemotherapy compared with concurrent chemoradiotherapy alone for the treatment of locally advanced nasopharyngeal carcinoma: a retrospective controlled study.The efficacy and toxicities of intensive induction chemotherapy followed by concurrent chemoradiotherapy in nasopharyngeal carcinoma patients with N3 disease.Efficacy and toxicity of docetaxel combination chemotherapy for advanced squamous cell cancer of the head and neck.Reduction of hyaluronan-CD44-mediated growth, migration, and cisplatin resistance in head and neck cancer due to inhibition of Rho kinase and PI-3 kinase signaling.Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy Therapeutic strategies with oral fluoropyrimidine anticancer agent, S-1 against oral cancer.

P2860

Q21198763-8BE1BBF7-D2B1-40A2-8245-388C873BEE3C Q24200362-960CBE6E-AD99-4017-B132-B8933DF70AD4 Q24200903-FC1BE101-7E76-4DBD-8EB1-2D77FEEAC0B5 Q24235245-5E0EEA51-B793-4593-8493-956C9827EACD Q26768434-B46CD16C-1B8A-4587-970C-C14927A2B45A Q26822621-7BC9C6DB-4463-4F39-8E4F-74FFF3EF6061 Q26830495-1932C41B-33E9-46A3-A87D-50F32D6345AD Q26859285-BE6F4709-2641-494D-BB27-0B3B554DC265 Q26863511-5E1F245F-A0AE-4164-B5D9-D42DDEBCFD30 Q27022454-9632FCFD-ACC1-4513-8611-6938E07B7E72 Q27026269-EE6AC522-1A05-43D8-A0CE-F4B2B643F8C9 Q27692688-A502445B-7D43-4DC2-86D1-365A0A670D95 Q28072336-A85D53DA-3267-4337-8123-4C2983D54A14 Q28079132-6E46E4EC-9186-4AAF-9071-AD4F3DB5ED74 Q28083540-1F808730-5ADE-4140-A19F-00D153666CE2 Q28391355-833FB3FE-433E-444C-9202-2E5D1547E5EF Q28468348-872B3F98-1265-4B6E-BEFC-AF264622F565 Q30498197-28CBB5FB-FD0D-4356-BB3A-B277A5369A75 Q31032091-E998A20B-03BA-4ADD-BFD1-1A8AE8DC19A1 Q31047791-2C54B9E5-2E7E-4497-A7AD-39C610C87AED Q31136094-E897E623-7E53-4A4D-B6DE-750EF7FA2D21 Q33380006-CCB700D6-E33C-4CFF-89F4-DEFFFDC93AE3 Q33383864-2CD01502-A432-4171-85C0-DF7CEA7EF7A2 Q33389563-70D9C2A9-F5A2-433F-B39B-ED44809D1ABD Q33393655-F180D3E2-4285-47A8-8ADB-00B2F9C07042 Q33400021-788430F2-C7F3-40E0-AF11-85E57AA6E449 Q33405880-4379E0D8-7B62-48D1-8F71-9F4DB85B3039 Q33426350-5B6EBEAC-CBE8-4B95-B8A7-5103A89FE834 Q33436548-750869C4-81AC-45A4-9E80-CE401C90E0FB Q33442582-4D4F3E20-E87D-453C-AACA-5541CB380F50 Q33491298-79DB5A86-BDE4-43DF-B43F-0758DC1DE4C7 Q33561959-81051501-2D04-4466-BAA1-692FCC9E1F7A Q33717319-0214B33A-D2A9-4E14-BE0E-42C3ABEBF49D Q33750798-02194FCE-A30B-4829-A93B-8BA2CF45D74A Q33763893-37F305D0-6CFE-4EE1-BCF8-520D8D042B15 Q33808152-68DA1A77-C36B-4679-9E09-45F26A86FEAB Q33858049-DE80F2CF-099B-4248-890D-127994A02E06 Q33867608-3AA0583D-F0F6-4CA6-82CA-E1146584C24B Q33884484-672A2FCF-985F-41AB-99D1-FD46C1654985 Q33884698-B438837E-9FB9-467A-8644-7AB5D4ED6FB1

P2860

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.

http://www.wikidata.org/entity/Q46932585

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.

@en

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.

@nl

type

label

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.

@en

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.

@nl

prefLabel

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.

@en

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.

@nl

P1433

Q46932585-58FF3BC9-A9DF-41AD-9938-5D9CB83E673A

P1476

Q46932585-D86E1988-1261-4B25-ACB2-BC0A7C73B046

P2093

Q46932585-033746DB-73AD-4790-8728-F459B7A996EA

Q46932585-053D7E28-725D-4441-8D20-CE68BA828F30

Q46932585-0FA8826F-EE44-429A-A4CE-02792F76620D

Q46932585-1104C100-000B-43DF-B7E7-DE9EB69F7FBD

Q46932585-14373E72-64E8-4F9B-8758-3B69F410A420

Q46932585-20129AF1-7D97-49FD-9912-BC7DFE68075D

Q46932585-21FB11FB-E352-4EF3-9CBC-3169C232AA7A

Q46932585-241297E8-BA80-4373-A7CE-204FCC612B7D

Q46932585-24839396-EB0C-4247-BF11-6F531BC520B8

Q46932585-2AF08933-3549-47CF-939D-3BDD6064D6C6

P304

Q46932585-899AFD85-1782-4DE7-B972-D96A345D51BD

P31

Q46932585-91D4D106-2FDB-4682-97CC-243D1FF41F97

P356

Q46932585-A2322C92-4AB7-4223-AF5F-875C7E1009D2

P407

Q46932585-45549F1C-B5AD-438E-AEAD-07D34A6DA129

P433

Q46932585-286324AA-F7E7-49A1-BE5C-39B1CE7FFFD4

P478

Q46932585-F92905C6-807F-4113-8BE2-7C07C53780F5

P577

Q46932585-7620A73D-9238-4E00-8D3F-2E195D9272E1

P698

Q46932585-BF264614-0BCE-41B7-9A8C-1DC57627EB9D

P356

P1433

The New England Journal of Medicine

P1476

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.

@en

P2093

A Dimitrios Colevas

http://www.w3.org/2001/XMLSchema#string

Anthony Cmelak

http://www.w3.org/2001/XMLSchema#string

Arnold M Markoe

http://www.w3.org/2001/XMLSchema#string

Barbara A Murphy

http://www.w3.org/2001/XMLSchema#string

Berta Roth

http://www.w3.org/2001/XMLSchema#string

Cesar R Blajman

http://www.w3.org/2001/XMLSchema#string

Charles M Norris

http://www.w3.org/2001/XMLSchema#string

Diane M Hershock

http://www.w3.org/2001/XMLSchema#string

Dong M Shin

http://www.w3.org/2001/XMLSchema#string

Elizabeth Mickiewicz

http://www.w3.org/2001/XMLSchema#string

P304

1705-1715

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA070956

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

357

http://www.w3.org/2001/XMLSchema#string

P577

2007-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17960013

http://www.w3.org/2001/XMLSchema#string